Activation of the pyrin inflammasome through the RhoA signaling pathway in FMF and HIDS

por Park, YH, Kastner, D, Chae, JJ
Publicado 2015

Cofilin-1 is an essential redox sensor for NLRP3 inflammasome activation

por Park, YH, Kastner, D, Chae, JJ
Publicado 2015

Potential role of CMPK1, SLC29A1, and TLE4 polymorphisms in gemcitabine-based chemotherapy in HER2-negative metastatic breast cancer patients: pharmacogenetic study results from th...

por Cho, E.H., Kim, J.-Y., Im, S.-A., Jung, K.H., Sohn, J., Lee, K.S., Chae, Y.S., Lee, K.H., Kim, J.H., Jang, J.-H., Ahn, J.H., Park, M.S., Lee, S.-Y., Park, Y.H.
Publicado 2021

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, staging and treatment of patients with metastatic breast cancer

por Im, S.-A., Gennari, A., Park, Y.H., Kim, J.H., Jiang, Z.-F., Gupta, S., Fadjari, T.H., Tamura, K., Mastura, M.Y., Abesamis-Tiambeng, M.L.T., Lim, E.H., Lin, C.-H., Sookprasert, A., Parinyanitikul, N., Tseng, L.-M., Lee, S.-C., Caguioa, P., Singh, M., Naito, Y., Hukom, R.A., Smruti, B.K., Wang, S.-S., Kim, S.B., Lee, K.-H., Ahn, H.K., Peters, S., Kim, T.W., Yoshino, T., Pentheroudakis, G., Curigliano, G., Harbeck, N.
Publicado 2023